Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWegovy 0.5mg is the second step in the semaglutide titration schedule, reached after four weeks on the 0.25mg starter dose. The only legal way to get it in the UK is through a valid prescription following a clinical assessment — and the quickest private route is a regulated online pharmacy whose prescribers can review and approve your consultation the same day. These are prescription-only medicines, so a clinician must decide whether they are appropriate for you before any supply can happen.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Wegovy treatment begins at 0.25mg weekly. That first month isn't intended to drive significant weight loss; it gives your body time to adjust to semaglutide before the dose increases. After approximately four weeks, your prescriber moves you to 0.5mg, the first step that begins to have a meaningful clinical effect, and if you're ready to order at that stage you can buy Wegovy 0.5mg through our pharmacy once a prescriber has confirmed it's appropriate. The schedule then continues at roughly monthly intervals: 1.0mg, then 1.7mg, and finally the 2.4mg maintenance dose (or 7.2mg for those who progress to the higher licensed maintenance, approved by the MHRA in January 2026).
One thing worth letting go of: the idea that a higher dose is automatically better or that reaching 0.5mg is somehow a slow start. The titration exists for a reason. Moving too quickly through the early steps tends to make gastrointestinal side effects (nausea, loose stools, indigestion) more noticeable than they need to be. Your prescriber sets the pace. Our Wegovy overview explains the full schedule in more detail if you'd like to read ahead.
At the 0.5mg stage most people are well into their treatment and will have had at least one clinical review since starting. If you've transferred from another service, your new prescriber will want to see evidence of where you are in that schedule before confirming the appropriate supply. That applies whether you come to us or to any other regulated provider.
Stock availability for Wegovy has improved considerably since the supply disruptions of 2023 and 2024, though it can still vary between pharmacies and across dose strengths. The MHRA has been clear on one thing throughout: semaglutide bought without a prescription from unverified online sellers carries serious risks. Fake pens have been seized in large numbers by enforcement teams, and some counterfeit products have been found to contain insulin rather than semaglutide, a genuinely dangerous substitution. You can report suspect sellers or products via the MHRA's Yellow Card scheme.
The safest starting point is always a pharmacy you can verify. Every legitimate UK online pharmacy must appear on the GPhC register, which you can search at pharmacyregulation.org. Red flags include sellers advertising these medicines without asking for a prescription, unusually low prices, and discount codes attached to prescription medicines, none of those are features of a regulated supply chain.
If you'd like to check whether your current treatment is available through us, our Wegovy stock page covers availability across dose strengths, and we also have a dedicated page if you want to see whether Wegovy 0.5mg is currently in stock or to find out whether Wegovy 1mg is in stock ahead of your next dose step. Specific dose availability is always confirmed during the consultation, because stock can move between the time you browse and the time a prescriber reviews your case.
The licensed eligibility criteria for Wegovy (semaglutide) in the UK cover adults with a BMI of 30 or above, or a BMI of 27 or above alongside at least one weight-related health condition, such as type 2 diabetes, high blood pressure, high cholesterol or obstructive sleep apnoea. For some ethnic backgrounds, UK clinical guidance applies thresholds 2.5 kg/m² lower than these standard figures. You can use the NHS BMI calculator to check your figure before starting a consultation.
BMI alone doesn't determine approval. A prescriber looks at the full picture: your medical history, any medicines you already take, whether you're pregnant or planning to become pregnant, and any conditions that would make semaglutide unsuitable. Wegovy is not licensed for people under 18, and it is not recommended during pregnancy, breastfeeding, or for those actively trying to conceive.
For people already established on Wegovy through another provider, reaching the 0.5mg step means your prescriber will want to see evidence of your current treatment and any dose changes to date. If you're looking locally, our page on finding Wegovy 0.5mg in stock near you may help you understand your options. NICE's guidance for semaglutide under technology appraisal TA875 covers the clinical criteria in full if you'd like the formal reference. Our prescribers review every case individually, so the best way to know whether you qualify is simply to start the free consultation.
The process is straightforward. You fill in a free online consultation, medical history, current weight, what you're taking, where you are in your treatment. A GPhC-registered Independent Prescriber at our pharmacy reads it and makes a clinical decision, typically the same working day. There's no automated triage standing between your answers and a qualified clinician.
Once approved, we dispatch before the end of the same day if your order comes in before 12pm Monday to Friday. Delivery is free, next working day, via DPD with full tracking and plain packaging. Every repeat order goes through the same clinical review; there are no subscriptions or automatic renewals.
If you have questions about what to expect before you start, our FAQ page covers the most common ones. You're also welcome to contact us directly. And if you'd like to know more about the clinical team overseeing prescribing, our lead prescriber's profile is there to read. When you're ready, check your eligibility here.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.